Tina J. Hieken, M.D.

  1. Surgical Oncologist
  1. Bartlett EK, O'Donoghue C, Boland G, Bowles T, Delman KA, Hieken TJ, Moncrieff M, Wong S, White RL Jr, Karakousis G, Society of Surgical Oncology Gene Expression Profiling Consensus Statement Work Group. Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Ann Surg Oncol. 2024 Oct 29 [Epub ahead of print]
    View PubMed
  2. Lohani KR, Hoskin TL, Yasir S, Olson CA, Boughey JC, Hieken TJ, Degnim AC. ASO Author Reflections: Time to Explore Minimally Invasive Axillary Nodal Staging After Neo-Adjuvant Chemotherapy in Inflammatory Breast Cancer. Ann Surg Oncol. 2024 Oct; 31 (11):7441-7442 Epub 2024 July 27
    View PubMed
  3. Jakub JW, Boughey JC, Hieken TJ, Piltin M, Forte AJ, Vijayasekaran A, Mazur M, Sturz J, Corbin K, Vallow L, Johnson JE, Mrdutt M, Fahradyan V, Li Z, Blumenfeld S, Degnim A, Yost KJ, Cheville A, McLaughlin SA. Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial. Ann Surg Oncol. 2024 Oct; 31 (11):7349-7359 Epub 2024 July 02
    View PubMed
  4. Lohani KR, Hoskin TL, Yasir S, Olson CA, Boughey JC, Hieken TJ, Degnim AC. Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Oct; 31 (11):7431-7440 Epub 2024 Aug 09
    View PubMed
  5. Mutter RW, Golafshar MA, Buras MR, Comstock BP, Jacobson M, DeWees T, Remmes NB, Francis LN, Boughey JC, Ruddy KJ, McGee LA, Afzal A, Vallow LA, Furutani KM, Deufel CL, Shumway DA, Kim H, Liu MC, Degnim AC, Jakub JW, Vern-Gross TZ, Wong WW, Patel SH, Vargas CE, Stish BJ, Waddle MR, Pafundi DH, Halyard MY, Corbin KS, Hieken TJ, Park SS. Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial. Int J Radiat Oncol Biol Phys. 2024 Sep 17 Epub 2024 Sept 17
    View PubMed
  6. Rosenberger LH, Thomas SM, Hieken TJ, Gallagher KK, Spanheimer PM, Neuman HB, Weiss AC, King TA, Wong J, Tong BS, Nash AL, Frazier MP, Menendez CS, Hwang ES, Jakub JW, Plichta JK. Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors. Breast Cancer Res Treat. 2024 Sep 13 Epub 2024 Sept 13
    View PubMed
  7. Steadman JA, Hieken TJ. Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer. J Surg Oncol. 2024 Sep; 130 (3):366-370 Epub 2024 Aug 05
    View PubMed
  8. Northrop A, Christofferson A, Umashankar S, Melisko M, Castillo P, Brown T, Heditsian D, Brain S, Simmons C, Hieken T, Ruddy KJ, Mainor C, Afghahi A, Tevis S, Blaes A, Kang I, Asare A, Esserman L, Hershman DL, Basu A. Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer. J Am Med Inform Assoc. 2024 Aug 19 [Epub ahead of print]
    View PubMed
  9. Steadman JA, Glasgow AE, Neequaye NN, Habermann EB, Hieken TJ. Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes. J Surg Oncol. 2024 May; 129 (6):1041-1050 Epub 2024 Mar 04
    View PubMed
  10. Olofsson Bagge R, Hieken TJ. A new era of risk prediction for patients with high-risk melanoma. Lancet Oncol. 2024 Apr; 25 (4):415-416
    View PubMed
  11. Davidson TM, Hieken TJ, Glasgow AE, Habermann EB, Yan Y. Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020. Melanoma Res. 2024 Apr 1; 34 (2):175-181 Epub 2024 Jan 23
    View PubMed
  12. Steadman JA, Hoskin TL, Klassen C, Boughey JC, Degnim AC, Piltin MA, Mrdutt MM, Johnson JE, Hieken TJ. Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer. Surgery. 2024 Mar; 175 (3):677-686 Epub 2023 Oct 19
    View PubMed
  13. Schulze AK, Hoskin TL, Mrdutt MM, Mutter RW, Hieken TJ. Repeat sentinel lymph node surgery for locally recurrent breast cancer after prior mastectomy. J Surg Oncol. 2024 Mar; 129 (3):461-467 Epub 2023 Nov 06
    View PubMed
  14. Ma CX, Suman VJ, Sanati S, Vij K, Anurag M, Leitch AM, Unzeitig GW, Hoog J, Fernandez-Martinez A, Fan C, Gibbs RA, Watson MA, Dockter TJ, Hahn O, Guenther JM, Caudle A, Crouch E, Tiersten A, Mita M, Razaq W, Hieken TJ, Wang Y, Rimawi MF, Weiss A, Winer EP, Hunt KK, Perou CM, Ellis MJ, Partridge AH, Carey LA. Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 1; 10 (3):362-371
    View PubMed
  15. Hieken TJ, Nelson GD, Flotte TJ, Grewal EP, Chen J, McWilliams RR, Kottschade LA, Yang L, Domingo-Musibay E, Dronca RS, Yan Y, Markovic SN, Dimou A, Montane HN, Erskine CL, Piltin MA, Price DL, Khariwala SS, Hui J, Strand CA, Harrington SM, Suman VJ, Dong H, Block MS. Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nat Commun. 2024 Feb 16; 15 (1):1430
    View PubMed
  16. Pavlick AC, Ariyan CE, Buchbinder EI, Davar D, Gibney GT, Hamid O, Hieken TJ, Izar B, Johnson DB, Kulkarni RP, Luke JJ, Mitchell TC, Mooradian MJ, Rubin KM, Salama AK, Shirai K, Taube JM, Tawbi HA, Tolley JK, Valdueza C, Weiss SA, Wong MK, Sullivan RJ. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. J Immunother Cancer. 2023 Oct; 11 (10)
    View PubMed
  17. Fastner S, Hieken TJ, McWilliams RR, Hyngstrom J. Anorectal melanoma. J Surg Oncol. 2023 Sep; 128 (4):635-644 Epub 2023 July 03
    View PubMed
  18. Stafford AP, Hoskin TL, Hieken TJ, Sanders S, Pruthi S, Boughey J, Degnim A. Lessons learned from the COVID-19 pandemic: Using telemedicine for pre-operative surgical evaluation in breast disease. J Telemed Telecare. 2023 Aug 24; 1357633X231194377 [Epub ahead of print]
    View PubMed
  19. Degnim AC, Siontis BL, Ahmed SK, Hoskin TL, Hieken TJ, Jakub JW, Baum CL, Day C, Schrup SE, Smith L, Carter JM, Sae-Kho TM, Sae Kho TM, Glazebrook KN, Vijayasekaran A, Okuno SH, Petersen IA. Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast. Clin Cancer Res. 2023 Aug 1; 29 (15):2885-2893
    View PubMed
  20. Kim H, Hieken TJ, Abraha F, Jakub JW, Corbin KS, Furutani KM, Boughey JC, Stish BJ, Deufel CL, Degnim AC, Shumway DA, Ahmed SK, Piltin MA, Sandhu NP, Conners AL, Ruddy KJ, Mutter RW, Park SS. Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data. Clin Transl Radiat Oncol. 2023 Jul; 41:100639 Epub 2023 May 09
    View PubMed
  21. Joshi U, Budhathoki P, Gaire S, Yadav SK, Shah A, Adhikari A, Choong G, Couzi R, Giridhar KV, Leon-Ferre RA, Boughey JC, Hieken TJ, Mutter R, Ruddy KJ, Haddad TC, Goetz MP, Couch FJ, Yadav S. Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2023 Jul; 200 (2):217-224 Epub 2023 May 21
    View PubMed
  22. Kottschade LA, Pond GR, Olszanski AJ, Zakharia Y, Domingo-Musibay E, Hauke RJ, Curti BD, Schober S, Milhem MM, Block MS, Hieken T, McWilliams RR. SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma. Clin Cancer Res. 2023 Jun 13; 29 (12):2220-2225
    View PubMed
  23. Broman KK, Hughes TM, Bredbeck BC, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, O'shea K, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Hotz M, Farma JM, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley GM, Hui JYC, Been L, Kruijff S, Sinco B, Sarnaik AA, Sondak VK, Zager JS, Dossett LA, International High Risk Melanoma Consortium. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers. Ann Surg. 2023 May 1; 277 (5):e1106-e1115 Epub 2023 Apr 06
    View PubMed
  24. Nash AL, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Hwang ES, Jakub JW, Rosenberger LH. Racial-ethnic variations in phyllodes tumors among a multicenter United States cohort. J Surg Oncol. 2023 Mar; 127 (3):369-373 Epub 2022 Oct 07
    View PubMed
  25. Piltin MA, Glasgow AE, Habermann EB, Hieken TJ. Intermediate-thickness melanoma: A population-based study of surgical quality metrics. Surgery. 2023 Mar; 173 (3):626-632 Epub 2022 Oct 29
    View PubMed
  26. Lillemoe HA, Williams JK, Teshome MK, Zheng L, Francescatti AB, Hieken TJ, Katz MH, Hunt KH, Vreeland TJ, Asare EA. Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. J Am Coll Surg. 2023 Feb 1; 236 (2):424-428 Epub 2022 Nov 14
    View PubMed
  27. Hieken TJ, Kreidieh F, Aedo-Lopez V, Block MS, McArthur GA, Amaria RN. Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift. Am Soc Clin Oncol Educ Book. 2023 Jan; 43:e390614
    View PubMed
  28. Broida SE, Chen XT, Baum CL, Brewer JD, Block MS, Jakub JW, Pockaj BA, Foote RL, Markovic SN, Hieken TJ, Houdek MT. Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes. J Surg Oncol. 2022 Nov; 126 (6):1080-1086 Epub 2022 July 09
    View PubMed
  29. Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, Carter JM, Chen B, Ahrendt G, Tchou J, Feldman M, Tousimis E, Zeck J, Jaskowiak N, Sattar H, Naik AM, Lee MC, Rosa M, Khazai L, Rendi MH, Lang JE, Lu J, Tawfik O, Asare SM, Esserman LJ, Mukhtar RA. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 Nov 1; 157 (11):1034-1041
    View PubMed
  30. Gonzalez TV, Sae-Kho TM, Robinson SI, Hieken TJ, Folpe AL, Broski SM, Degnim AC, Glazebrook KN. Radiation-associated angiosarcoma of the breast with initial presentation as non-mass enhancement on MRI. Radiol Case Rep. 2022 Oct; 17(10):3624-3629. Epub 2022 Jul 29.
    View PubMed
  31. Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou T. Innovation in Breast Surgery: Practical and Ethical Considerations. Ann Surg Oncol. 2022 Oct; 29 (10):6144-6150 Epub 2022 July 19
    View PubMed
  32. Sanders SB, Hoskin TL, Solanki MH, Stafford AP, Boughey JC, Hieken TJ. Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma. Ann Surg Oncol. 2022 Oct; 29 (10):6458-6465 Epub 2022 July 18
    View PubMed
  33. Robbins T, Hoskin TL, Day CN, Mrdutt MM, Hieken TJ, Jakub JW, Glazebrook K, Boughey JC, Degnim AC. Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. Ann Surg Oncol. 2022 Oct; 29 (10):6276-6287 Epub 2022 July 19
    View PubMed
  34. Hieken TJ, Burns WR, Francescatti AB, Morris AM, Wong SL, Cancer Surgery Standards Program of the American College of Surgeons. Technical Standards for Cancer Surgery: Improving Patient Care through Synoptic Operative Reporting. Ann Surg Oncol. 2022 Oct; 29 (11):6526-6533 Epub 2022 Feb 16
    View PubMed
  35. Yadav S, Sangaralingham L, Payne SR, Giridhar KV, Hieken TJ, Boughey JC, Mutter RW, Hawse JR, Jimenez RE, Freedman RA, Khanani S, Couch FJ, Vachon C, Shah N, Leon-Ferre RA, Ruddy KJ. Surveillance mammography after treatment for male breast cancer. Breast Cancer Res Treat. 2022 Aug; 194(3):693-698. Epub 2022 Jun 17.
    View PubMed
  36. van Akkooi ACJ, Hieken TJ, Burton EM, Ariyan C, Ascierto PA, Asero SVMA, Blank CU, Block MS, Boland GM, Caraco C, Chng S, Davidson BS, Duprat Neto JP, Faries MB, Gershenwald JE, Grunhagen DJ, Gyorki DE, Han D, Hayes AJ, van Houdt WJ, Karakousis GC, Klop WMC, Long GV, Lowe MC, Menzies AM, Bagge RO, Pennington TE, Rutkowski P, Saw RPM, Scolyer RA, Shannon KF, Sondak VK, Tawbi H, Testori AAE, Tetzlaff MT, Thompson JF, Zager JS, Zuur CL, Wargo JA, Spillane AJ, Ross MI, International Neoadjuvant Melanoma Consortium (INMC). Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Ann Surg Oncol. 2022 Aug; 29 (8):5241-5242
    View PubMed
  37. Eroglu Z, Broman KK, Thompson JF, Nijhuis A, Hieken TJ, Kottschade L, Farma JM, Hotz M, Deneve J, Fleming M, Bartlett EK, Sharma A, Dossett L, Hughes T, Gyorki DE, Downs J, Karakousis G, Song Y, Lee A, Berman RS, van Akkooi A, Stahlie E, Han D, Vetto J, Beasley G, Farrow NE, Hui JYC, Moncrieff M, Nobes J, Baecher K, Perez M, Lowe M, Ollila DW, Collichio FA, Bagge RO, Mattsson J, Kroon HM, Chai H, Teras J, Sun J, Carr MJ, Tandon A, Babacan NA, Kim Y, Naqvi M, Zager J, Khushalani NI. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. J Immunother Cancer. 2022 Aug; 10 (8)
    View PubMed
  38. Hieken TJ, Sadurni MB, Quattrocchi E, Kobic A, Sominidi-Damodaran S, Dwarkasing JT, Meerstein-Kessel L, Bridges AG, Meves A. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study. Int J Dermatol. 2022 Jul; 61 (7):848-854 Epub 2022 Jan 31
    View PubMed
  39. Holmberg CJ, Ny L, Hieken TJ, Block MS, Carr MJ, Sondak VK, Ortenwall C, Katsarelias D, Dimitriou F, Menzies AM, Saw RP, Rogiers A, Straker RJ 3rd, Karakousis G, Applewaite R, Pallan L, Han D, Vetto JT, Gyorki DE, Tie EN, Vitale MG, Ascierto PA, Dummer R, Cohen J, Hui JY, Schachter J, Asher N, Helgadottir H, Chai H, Kroon H, Coventry B, Rothermel LD, Sun J, Carlino MS, Duncan Z, Broman K, Weber J, Lee AY, Berman RS, Teras J, Ollila DW, Long GV, Zager JS, van Akkooi A, Olofsson Bagge R. The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study. Eur J Cancer. 2022 Jul; 169:210-222 Epub 2022 May 26
    View PubMed
  40. van Akkooi ACJ, Hieken TJ, Burton EM, Ariyan C, Ascierto PA, Asero SVMA, Blank CU, Block MS, Boland GM, Caraco C, Chng S, Davidson BS, Duprat Neto JP, Faries MB, Gershenwald JE, Grunhagen DJ, Gyorki DE, Han D, Hayes AJ, van Houdt WJ, Karakousis GC, Klop WMC, Long GV, Lowe MC, Menzies AM, Olofsson Bagge R, Pennington TE, Rutkowski P, Saw RPM, Scolyer RA, Shannon KF, Sondak VK, Tawbi H, Testori AAE, Tetzlaff MT, Thompson JF, Zager JS, Zuur CL, Wargo JA, Spillane AJ, Ross MI, International Neoadjuvant Melanoma Consortium (INMC). Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Ann Surg Oncol. 2022 Jun; 29 (6):3694-3708 Epub 2022 Jan 28
    View PubMed
  41. Hieken TJ, Chen J, Chen B, Johnson S, Hoskin TL, Degnim AC, Walther-Antonio MR, Chia N. The breast tissue microbiome, stroma, immune cells and breast cancer. Neoplasia. 2022 May; 27:100786 Epub 2022 Mar 30
    View PubMed
  42. Racz JM, Harless CA, Hoskin TL, Day CN, Nguyen MT, Harris AM, Boughey JC, Hieken TJ, Degnim AC. Sexual Well-Being After Nipple-Sparing Mastectomy: Does Preservation of the Nipple Matter? Ann Surg Oncol. 2022 Apr 6 Epub 2022 Apr 06
    View PubMed
  43. Rentroia-Pacheco B, Tjien-Fooh FJ, Quattrocchi E, Kobic A, Wever R, Bellomo D, Meves A, Hieken TJ. Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node? J Surg Oncol. 2022 Mar; 125 (3):516-524 Epub 2021 Nov 04
    View PubMed
  44. Hieken TJ, Price DL, Piltin MA, Turner HJ, Block MS. Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma. Ann Surg Oncol. 2022 Feb; 29 (2):780-786 Epub 2021 Nov 25
    View PubMed
  45. Hieken TJ, Price DL, Piltin MA, Turner HJ, Block MS. ASO Visual Abstract: Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma. Ann Surg Oncol. 2022 Feb; 29 (2):789-790
    View PubMed
  46. Hieken TJ, Burns WR, Francescatti AB, Morris AM, Wong SL, Cancer Surgery Standards Program of the American College of Surgeons. ASO Visual Abstract: Technical Standards for Cancer Surgery-Improving Patient Care through Synoptic Operative Reporting. Ann Surg Oncol. 2022 Jan 29 [Epub ahead of print]
    View PubMed
  47. Murphy BM, Hoskin TL, Degnim AC, Boughey JC, Hieken TJ. Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy. Ann Surg Oncol. 2021 Dec; 28 (13):8729-8739 Epub 2021 July 17
    View PubMed
  48. Asaad M, Yonkus JA, Hoskin TL, Hieken TJ, Jakub JW, Boughey JC, Degnim AC. Primary tumor resection in patients with stage IV breast cancer: 10-year experience. Breast J. 2021 Dec; 27 (12):863-871 Epub 2021 Oct 14
    View PubMed
  49. Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol 2021 Dec; 28 (Suppl 3):465-466
    View PubMed
  50. Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol. 2021 Nov; 28 (12):7404-7409 Epub 2021 May 14
    View PubMed
  51. Davis J Jr, Boughey JC, Hoskin TL, Day CN, Cheville JC, Piltin MA, Hieken TJ. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology. Clin Breast Cancer. 2021 Oct; 21 (5):458-465 Epub 2021 Mar 13
    View PubMed
  52. Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer. 2021 Jul 1; 127 (13):2251-2261 Epub 2021 Apr 07
    View PubMed
  53. Broman KK, Hughes TM, Dossett LA, Sun J, Carr MJ, Kirichenko DA, Sharma A, Bartlett EK, Nijhuis AA, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma J, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras RM, Teras J, Farrow NE, Beasley GM, Hui JY, Been L, Kruijff S, Boulware D, Sarnaik AA, Sondak VK, Zager JS, International High-Risk Melanoma Consortium. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. J Am Coll Surg. 2021 Apr; 232 (4):424-431 Epub 2020 Dec 13
    View PubMed
  54. Leon-Ferre RA, Hieken TJ, Boughey JC. The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer. Ann Surg Oncol. 2021 Apr; 28 (4):2111-2119 Epub 2021 Jan 23
    View PubMed
  55. Pride RM, Jimenez RE, Hoskin TL, Degnim AC, Hieken TJ. Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ. Surgery. 2021 Mar; 169 (3):644-648 Epub 2020 Aug 26
    View PubMed
  56. Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines. J Clin Oncol. 2021 Jan 20; 39 (3):178-189 Epub 2020 Dec 10
    View PubMed
  57. Racz JM, Glasgow AE, Keeney GL, Degnim AC, Hieken TJ, Jakub JW, Cheville JC, Habermann EB, Boughey JC. Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery. Ann Surg Oncol. 2020 Dec; 27 (13):5303-5311 Epub 2020 July 04
    View PubMed
  58. Eggermont AMM, Bellomo D, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Murphree DH, Pittelkow MR, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, Rentroia-Pacheco B, Wever R, van Vliet MH, Dwarkasing J, Meves A. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model. Eur J Cancer. 2020 Nov; 140:11-18 Epub 2020 Oct 05
    View PubMed
  59. Asaad M, Meaike J, Yonkus J, Hoskin T, Hieken T, Martinez-Jorge J, Tran N, Nguyen MD, Boughey J, Degnim AC. Breast Reconstruction in the Setting of Stage 4 Breast Cancer: Is It Worthwhile? Ann Surg Oncol. 2020 Nov; 27 (12):4730-4739 Epub 2020 Aug 25
    View PubMed
  60. Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, Jakub JW. Germline Genetic Mutations in a Multi-center Contemporary Cohort of 550 Phyllodes Tumors: An Opportunity for Expanded Multi-gene Panel Testing. Ann Surg Oncol. 2020 Oct; 27 (10):3633-3640 Epub 2020 June 05
    View PubMed
  61. Hieken TJ, Glasgow AE, Enninga EAL, Kottschade LA, Dronca RS, Markovic SN, Block MS, Habermann EB. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort. J Womens Health (Larchmt). 2020 Sep; 29 (9):1160-1167 Epub 2020 Feb 27
    View PubMed
  62. Kupstas AR, Hoskin TL, Day CN, Boughey JC, Habermann EB, Hieken TJ. Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database. Br J Surg. 2020 Jul; 107 (8):1033-1041 Epub 2020 Feb 14
    View PubMed
  63. Hallbeck MS, Law KE, Lowndes BR, Linden AR, Morrow M, Blocker RC, Cain SM, Degnim AC, Hieken TJ, Jakub JW, Racz JM, Farley DR, Nelson H, Boughey JC. Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM. Ann Surg Oncol. 2020 May; 27 (5):1318-1326 Epub 2020 Jan 08
    View PubMed
  64. Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle A, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton N. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol. 2020 Apr 20; 38 (12):1284-1292 Epub 2020 Mar 03
    View PubMed
  65. Banuelos J, Taslakian EN, Nguyen MT, Manrique OJ, Tran NV, Martinez-Jorge J, Hieken T, Jakub J, Habermann EB, Sharaf B. The American College of Surgeons National Quality Improvement Program Incompletely Captures Implant-Based Breast Reconstruction Complications. Ann Plast Surg. 2020 Mar; 84 (3):271-275
    View PubMed
  66. Bellomo D, Arias-Mejias SM, Ramana C, Heim JB, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Pittelkow MR, DiCaudo DJ, Pockaj BA, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, van Vliet MH, Dwarkasing J, Meves A. Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. JCO Precis Oncol. 2020; 4:319-334 Epub 2020 Apr 14
    View PubMed
  67. Yadav S, Karam D, Bin Riaz I, Xie H, Durani U, Duma N, Giridhar KV, Hieken TJ, Boughey JC, Mutter RW, Hawse JR, Jimenez RE, Couch FJ, Leon-Ferre RA, Ruddy KJ. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. 2020 Jan 1; 126 (1):26-36 Epub 2019 Oct 07
    View PubMed
  68. Ruddy KJ, Herrin J, Sangaralingham L, Freedman RA, Jemal A, Haddad TC, Allen SV, Hieken T, Boughey JC, Ganz PA, Havyer RD, Shah ND. Follow-up Care for Breast Cancer Survivors. J Natl Cancer Inst 2020 Jan 1; 112 (1):111-113
    View PubMed
  69. Bellomo D, Bridges AG, Hieken TJ, Meves A. Reply to E. K. Bartlett et al and A. H. R. Varey et al. JCO Precis Oncol. 2020; 4:992-994 Epub 2020 Sept 03
    View PubMed
  70. Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B. Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg. 2019 Dec; 144 (6):1270-1277
    View PubMed
  71. Mutter RW, Jethwa KR, Gonuguntla K, Remmes NB, Whitaker TJ, Hieken TJ, Ruddy KJ, McGee LA, Corbin KS, Park SS. 3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen. Radiat Oncol. 2019 Nov 21; 14 (1):211
    View PubMed
  72. Young WA, Degnim AC, Hoskin TL, Jakub JW, Nguyen MD, Tran NV, Harless CA, Manrique OJ, Boughey JC, Hieken TJ. Outcomes of > 1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications. Ann Surg Oncol. 2019 Oct; 26 (10):3115-3123 Epub 2019 July 24
    View PubMed
  73. Sada A, Day CN, Hoskin TL, Degnim AC, Habermann EB, Hieken TJ. Mastectomy and immediate breast reconstruction in the elderly: Trends and outcomes. Surgery. 2019 Oct; 166 (4):709-714 Epub 2019 Aug 05
    View PubMed
  74. Manrique OJ, Charafeddine A, Abu-Ghname A, Banuelos J, Jacobson SR, Martinez-Jorge J, Nguyen MD, Harless C, Tran NV, Sharaf B, Jakub JW, Hieken TJ, Degnim AC, Boughey JC. Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population. Medicina (Kaunas). 2019 Aug 14; 55 (8)
    View PubMed
  75. Murphy BL, Glasgow AE, Habermann EB, Hieken TJ. Returns to the operating room after breast surgery at a tertiary care medical center. Am J Surg. 2019 Aug; 218 (2):388-392 Epub 2019 Feb 20
    View PubMed
  76. Jethwa KR, Park SS, Gonuguntla K, Wick SM, Vallow LA, Deufel CL, Whitaker TJ, Furutani KM, Ruddy KJ, Corbin KS, Hieken TJ, Mutter RW. In Reply to Hannoun-Levi and Hannoun. Int J Radiat Oncol Biol Phys 2019 Aug 1; 104 (5):1177-1179 Epub 2019 Apr 27
    View PubMed
  77. Murphy BL, Hanson KT, Hieken TJ, McLaughlin S, Gray RJ, Habermann EB. Patient-reported experience after outpatient breast surgery. Am J Surg. 2019 Jul; 218 (1):175-180 Epub 2018 Dec 08
    View PubMed
  78. Jethwa KR, Park SS, Gonuguntla K, Wick SM, Vallow LA, Deufel CL, Whitaker TJ, Furutani KM, Ruddy KJ, Corbin KS, Hieken TJ, Mutter RW. Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen. Int J Radiat Oncol Biol Phys. 2019 May 1; 104 (1):75-82 Epub 2018 Dec 21
    View PubMed
  79. Hieken TJ, Kane JM 3rd, Wong SL. The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma. Ann Surg Oncol. 2019 Apr; 26 (4):1028-1034 Epub 2018 Oct 03
    View PubMed
  80. Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, I-SPY2 Investigators. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2019; 5:2 Epub 2019 Jan 02
    View PubMed
  81. Zhang Y, Mutter RW, Park SS, Hieken TJ, Yan ES, Corbin KS, Brinkmann DH, Pafundi DH. Carbon Fiducial Image Guidance Increases the Accuracy of Lumpectomy Cavity Localization in Radiation Therapy for Breast Cancer. Pract Radiat Oncol. 2019 Jan; 9 (1):e14-e21 Epub 2018 Oct 01
    View PubMed
  82. Maus RLG, Jakub JW, Hieken TJ, Nevala WK, Christensen TA, Sutor SL, Flotte TJ, Markovic SN. Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma. Oncoimmunology. 2019; 8 (12):e1667742 Epub 2019 Sept 30
    View PubMed
  83. Samreen N, Lee C, Bhatt A, Carter J, Hieken T, Adler K, Zingula S, Glazebrook KN. A Clinical Approach to Diffusion-Weighted Magnetic Resonance Imaging in Evaluating Chest Wall Invasion of Breast Tumors. J Clin Imaging Sci. 2019; 9:11 Epub 2019 Apr 30
    View PubMed
  84. Leon-Ferre RA, Giridhar KV, Hieken TJ, Mutter RW, Couch FJ, Jimenez RE, Hawse JR, Boughey JC, Ruddy KJ. A contemporary review of male breast cancer: current evidence and unanswered questions. Cancer Metastasis Rev. 2018 Dec; 37 (4):599-614
    View PubMed
  85. Gao RW, Park SS, Jakub JW, Hieken TJ, Conners AL, Neal L, Pruthi S, Corbin KS, Yan ES, Mutter RW, Stish BJ. Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient. Pract Radiat Oncol. 2018 Nov - Dec; 8 (6):361-365 Epub 2018 Mar 18
    View PubMed
  86. Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast. Ann Surg Oncol. 2018 Oct; 25 (10):3064-3068 Epub 2018 June 26
    View PubMed
  87. Nguyen TT, VanderWalde L, Bellavance E, Eisenhauer T, Hieken T, Johnson N, Kaufman DI, O'Neill J, Patten CR, Teller P, Tevis S, Sarantou T, Throckmorton A. Ethical Considerations of Medical Photography in the Management of Breast Disease. Ann Surg Oncol. 2018 Oct; 25 (10):2801-2806 Epub 2018 July 05
    View PubMed
  88. Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC. Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Sep; 25 (9):2596-2602 Epub 2018 July 05
    View PubMed
  89. Hieken TJ, Murphy BL, Boughey JC, Degnim AC, Glazebrook KN, Hoskin TL. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes. Clin Breast Cancer. 2018 Aug; 18 (4):e501-e506 Epub 2017 Oct 07
    View PubMed
  90. Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC. Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. J Clin Oncol. 2018 Jun 20; 36 (18):1840-1846 Epub 2018 Apr 20
    View PubMed
  91. Jakub JW, Racz JM, Hieken TJ, Gonzalez AB, Kottschade LA, Markovic SN, Yan Y, Block MS. Neoadjuvant systemic therapy for regionally advanced melanoma. J Surg Oncol. 2018 May; 117 (6):1164-1169 Epub 2017 Dec 11
    View PubMed
  92. Jethwa KR, Kahila MM, Mara KC, Harmsen WS, Routman DM, Pumper GM, Corbin KS, Sloan JA, Ruddy KJ, Hieken TJ, Park SS, Mutter RW. Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience. Breast Cancer Res Treat. 2018 May; 169 (1):189-196 Epub 2018 Jan 18
    View PubMed
  93. Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, Jemal A, Duma N, Haddad TC, Lemaine V, Ghosh K, Hieken TJ, Hunt K, Vachon C, Gross C, Shah ND. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. J Natl Compr Canc Netw. 2018 May; 16 (5):526-534
    View PubMed
  94. Murphy BL, Gonzalez AB, Keeney MG, Chen B, Conners AL, Henrichsen TL, Degnim AC, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Jakub JW. Ability of Intraoperative Pathologic Analysis of Ductal Carcinoma In Situ to Guide Selective Use of Sentinel Lymph Node Surgery. Am Surg. 2018 Apr 1; 84 (4):537-542
    View PubMed
  95. Murphy BL, Fazzio RT, Hoskin TL, Glazebrook KN, Keeney MG, Habermann EB, Hieken TJ. Management of the axilla in metaplastic breast carcinoma. Gland Surg. 2018 Apr; 7 (2):200-206
    View PubMed
  96. Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, and I-SPY 2 Investigators. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2018; 4:26 Epub 2018 Aug 17
    View PubMed
  97. Ma CX, Suman V, Goetz MP, Northfelt D, Burkard ME, Ademuyiwa F, Naughton M, Margenthaler J, Aft R, Gray R, Tevaarwerk A, Wilke L, Haddad T, Moynihan T, Loprinzi C, Hieken T, Barnell EK, Skidmore ZL, Feng YY, Krysiak K, Hoog J, Guo Z, Nehring L, Wisinski KB, Mardis E, Hagemann IS, Vij K, Sanati S, Al-Kateb H, Griffith OL, Griffith M, Doyle L, Erlichman C, Ellis MJ. A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer. Clin Cancer Res. 2017 Nov 15; 23(22):6823-6832. Epub 2017 Sep 05.
    View PubMed
  98. Welsh JL, Keeney MG, Hoskin TL, Glazebrook KN, Boughey JC, Shah SS, Hieken TJ. Is axillary surgery beneficial for patients with adenoid cystic carcinoma of the breast? J Surg Oncol. 2017 Nov; 116 (6):690-695 Epub 2017 June 12
    View PubMed
  99. Pandian TK, Krishnamurthy V, Hieken TJ. The impact of patient, physician and tumor factors on awareness and early diagnosis of cutaneous melanoma J Dermatol Res Therapy. 2017; 3:49.
  100. Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone S 4th, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, Musonza T, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Shah HN, Degnim AC. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease. Ann Surg Oncol. 2017 Oct; 24 (10):2915-2924 Epub 2017 Aug 01
    View PubMed
  101. Nguyen TT, Hieken TJ, Glazebrook KN, Boughey JC. Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges. Ann Surg Oncol. 2017 Oct; 24 (10):3011-3016 Epub 2017 Aug 01
    View PubMed
  102. Enninga EAL, Moser JC, Weaver AL, Markovic SN, Brewer JD, Leontovich AA, Hieken TJ, Shuster L, Kottschade LA, Olariu A, Mansfield AS, Dronca RS. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011. Cancer Med. 2017 Oct; 6 (10):2203-2212 Epub 2017 Sept 06
    View PubMed
  103. Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ. NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4055-4065. Epub 2017 Mar 07.
    View PubMed
  104. Pena A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017 Jul; 164 (2):295-304 Epub 2017 May 04
    View PubMed
  105. Murphy BL, Boughey JC, Hieken TJ. Nipple-sparing Mastectomy for the Management of Recurrent Breast Cancer. Clin Breast Cancer. 2017 Jul; 17 (4):e209-e213 Epub 2017 Jan 09
    View PubMed
  106. Gibreel WO, Day CN, Hoskin TL, Boughey JC, Habermann EB, Hieken TJ. Mastectomy and Immediate Breast Reconstruction for Cancer in the Elderly: A National Cancer Data Base Study. J Am Coll Surg. 2017 May; 224 (5):895-905 Epub 2017 Feb 23
    View PubMed
  107. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Jakub JW, Krajewski AC, Jacobson SR, Hieken TJ. Outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer Patients. Am J Surg. 2017 Apr; 213 (4):810-813 Epub 2016 Sept 03
    View PubMed
  108. Anderson TL, Glazebrook KN, Murphy BL, Viers LD, Hieken TJ. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy. Eur J Radiol. 2017 Apr; 89:163-168 Epub 2017 Feb 07
    View PubMed
  109. Maus RLG, Jakub JW, Nevala WK, Christensen TA, Noble-Orcutt K, Sachs Z, Hieken TJ, Markovic SN. Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation. Front Immunol. 2017; 8:358 Epub 2017 Mar 29
    View PubMed
  110. Fahy AS, Grotz TE, Keeney GL, Glasgow AE, Habermann EB, Erickson L, Hieken TJ, Jakub JW. Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation. J Surg Oncol. 2016 Dec; 114: (7)879-883.
    View PubMed
  111. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. Erratum to: A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol. 2016 Dec; 23 (Suppl 5):1059
    View PubMed
  112. Stish BJ, Pafundi DH, Hieken TJ, Whitaker TJ, Furutani KM, Jakub JW, Boughey JC, Degnim AC, McLemore LB, Mou B, Mutter RW, Park SS. Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation Brachytherapy. 2016 Nov-dec; 15(6):796-803. Epub 1900 Jan 01.
    View PubMed
  113. Murphy BL, Boughey JC, Degnim AC, Hieken TJ, Harmsen WS, Keeney GL, Jakub JW. A Picture is Worth a Thousand Words: Intraoperative Photography as a Quality Metric for Axillary Dissection. Ann Surg Oncol. 2016 Oct; 23 (11):3494-3500 Epub 2016 May 19
    View PubMed
  114. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Carter JM, Glazebrook KN, Hieken TJ. Contemporary operative management of T4 breast cancer. Surgery. 2016 Oct; 160 (4):1059-1069 Epub 2016 Aug 09
    View PubMed
  115. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol. 2016 Oct; 23 (10):3297-303 Epub 2016 June 22
    View PubMed
  116. Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW. Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer. 2016 Oct; 122 (19):2971-8 Epub 2016 June 28
    View PubMed
  117. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Glazebrook KN, Hieken TJ. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer. Ann Surg Oncol. 2016 Oct; 23 (10):3365-70 Epub 2016 June 30
    View PubMed
  118. Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, Yao JZ, Baddour LM, Chia N, Degnim AC. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Sci Rep. 2016 Aug 3; 6:30751 Epub 2016 Aug 03
    View PubMed
  119. Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery. 2016 Apr; 159 (4):1199-209 Epub 2015 Dec 17
    View PubMed
  120. Leonard J, Hieken TJ, Hussein M, Harmsen WS, Sawyer M, Osborn J, Bingener J. Delineation of factors associated with prolonged length of stay after laparoscopic ventral hernia repair leads to a clinical pathway and improves quality of care. Surg Endosc. 2016 Apr; 30 (4):1614-8 Epub 2015 July 14
    View PubMed
  121. Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016 Feb 1; 122 (3):378-85 Epub 2015 Oct 29
    View PubMed
  122. Abdelsattar JM, Boughey JC, Fahy AS, Jakub JW, Farley DR, Hieken TJ, Degnim AC, Goede W, Mohan AT, Harmsen WS, Niesen AD, Tran NV, Bakri K, Jacobson SR, Lemaine V, Saint-Cyr M. Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction. Ann Surg Oncol. 2016 Feb; 23 (2):465-70 Epub 2015 Aug 26
    View PubMed
  123. Kasi PM, Hieken TJ, Haddad TC. Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer. Case Rep Oncol. 2016 Jan-Apr; 9 (1):33-8 Epub 2016 Jan 14
    View PubMed
  124. Krajewski AC, Hart DR, Hieken TJ. Multiple primary melanoma in the elderly. Am J Surg. 2016 Jan; 211: (1)84-8.
    View PubMed
  125. Erdahl LM, Boughey JC, Hoskin TL, Degnim AC, Hieken TJ. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing. Ann Surg Oncol. 2016 Jan; 23: (1)72-7.
    View PubMed
  126. Hieken TJ, Carter JM, Hawse JR, Hoskin TL, Bois M, Frost M, Hartmann LC, Radisky DC, Visscher DW, Degnim AC. ERbeta expression and breast cancer risk prediction for women with atypias. Cancer Prev Res (Phila). 2015 Nov; 8 (11):1084-92 Epub 2015 Aug 14
    View PubMed
  127. Al-Hilli Z, Boughey JC, Hoskin TL, Heins CN, Hieken TJ. Increasing Use of Neoadjuvant Treatment for T1 and T2 HER2-Positive Tumors. Ann Surg Oncol. 2015 Oct; 22 (10):3369-75 Epub 2015 July 23
    View PubMed
  128. Dupont SC, Boughey JC, Jimenez RE, Hoskin TL, Hieken TJ. Frequency of diagnosis of cancer or high-risk lesion at operation for pathologic nipple discharge. Surgery. 2015 Oct; 158: (4)988-94; discussion 994-5.
    View PubMed
  129. Al-Hilli Z, Hieken TJ, Hoskin TL, Heins CN, Boughey JC. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease. J Surg Oncol. 2015 Oct; 112: (5)453-7.
    View PubMed
  130. Krajewski AC, Boughey JC, Degnim AC, Jakub JW, Jacobson SR, Hoskin TL, Hieken TJ. Expanded Indications and Improved Outcomes for Nipple-Sparing Mastectomy Over Time. Ann Surg Oncol. 2015 Oct; 22 (10):3317-23 Epub 2015 July 23
    View PubMed
  131. Zhang Y, Hieken TJ, Mutter RW, Park S, Brinkmann D, Pafundi D. SU-E-J-37: Feasibility of utilizing carbon fiducials to increase localization accuracy of lumpectomy cavity for partial breast irradiation Medical Physicis.06/2015;42:(6):3271.
  132. Hieken TJ, Grotz TE, Comfere NI, Inselman JW, Habermann EB. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma. Melanoma Res. 2015 Apr; 25 (2):157-63
    View PubMed
  133. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015 Mar 10; 33 (8):923-9 Epub 2015 Jan 26
    View PubMed
  134. Nassar A, Conners AL, Celik B, Jenkins SM, Smith CY, Hieken TJ. Radial scar/complex sclerosing lesions: a clinicopathologic correlation study from a single institution. Ann Diagn Pathol. 2015 Feb; 19(1):24-8. Epub 2014 Dec 20.
    View PubMed
  135. Grotz TE, Puig CA, Perkins S, Ballman K, Hieken TJ. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications. Eur J Surg Oncol. 2015 Jan; 41(1):157-64. Epub 2014 Oct 30.
    View PubMed
  136. Habermann EB, Thomsen KM, Hieken TJ, Boughey JC. Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. Ann Surg Oncol. 2014 Oct; 21 (10):3290-6 Epub 2014 July 23
    View PubMed
  137. Shah AR, Glazebrook KN, Boughey JC, Hoskin TL, Shah SS, Bergquist JR, Dupont SC, Hieken TJ. Does BMI affect the accuracy of preoperative axillary ultrasound in breast cancer patients? Ann Surg Oncol. 2014 Oct; 21(10):3278-83. Epub 2014 Jul 30.
    View PubMed
  138. Degnim AC, Hoskin TL, Brahmbhatt RD, Warren-Peled A, Loprinzi M, Pavey ES, Boughey JC, Hieken TJ, Jacobson S, Lemaine V, Jakub JW, Irwin C, Foster RD, Sbitany H, Saint-Cyr M, Duralde E, Ramaker S, Chin R, Sieg M, Wildeman M, Scow JS, Patel R, Ballman K, Baddour LM, Esserman LJ. Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstruction. Ann Surg Oncol. 2014 Oct; 21 (10):3240-8 Epub 2014 Aug 06
    View PubMed
  139. Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome. Ann Surg Oncol. 2014 Oct; 21(10):3304-9. Epub 2014 Jul 18.
    View PubMed
  140. Boughey JC, Hieken TJ, Jakub JW, Degnim AC, Grant CS, Farley DR, Thomsen KM, Osborn JB, Keeney GL, Habermann EB. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the National Surgical Quality Improvement Program data. Surgery. 2014 Jul; 156 (1):190-7 Epub 2014 Mar 18
    View PubMed
  141. Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA, Wahner-Roedler DL, Ghosh K, Visscher DW. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc. 2014 Apr; 89 (4):536-47
    View PubMed
  142. Dilaveri CA, Sandhu NP, Neal L, Neben-Wittich MA, Hieken TJ, Mac Bride MB, Wahner-Roedler DL, Ghosh K. Medical factors influencing decision making regarding radiation therapy for breast cancer. Int J Womens Health. 2014; 6:945-54 Epub 2014 Nov 19
    View PubMed
  143. Hieken TJ, Boughey JC, Jones KN, Shah SS, Glazebrook KN. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol. 2013 Oct; 20(10):3199-204. Epub 2013 Jul 12.
    View PubMed
  144. Hieken TJ, Trull BC, Boughey JC, Jones KN, Reynolds CA, Shah SS, Glazebrook KN. Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. Surgery. 2013 Oct; 154 (4):831-8; discussion 838-40
    View PubMed
  145. Swapp RE, Glazebrook KN, Jones KN, Brandts HM, Reynolds C, Visscher DW, Hieken TJ. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013 Jun; 20 (6):1900-5 Epub 2013 Jan 13
    View PubMed
  146. Grotz TE, Vaince F, Hieken TJ. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes. Melanoma Res. 2013 Apr; 23 (2):132-7
    View PubMed
  147. Mac Bride MB, Neal L, Dilaveri CA, Sandhu NP, Hieken TJ, Ghosh K, Wahner-Roedler DL. Factors associated with surgical decision making in women with early-stage breast cancer: a literature review. J Womens Health (Larchmt). 2013 Mar; 22 (3):236-42 Epub 2013 Feb 21
    View PubMed
  148. Hieken TJ, Hernandez-Irizarry R, Boll JM, Jones Coleman JE. Accuracy of diagnostic biopsy for cutaneous melanoma: implications for surgical oncologists. Int J Surg Oncol. 2013; 2013:196493 Epub 2013 Sept 11
    View PubMed
  149. Brahmbhatt RD, Huebner M, Scow JS, Harmsen WS, Boughey JC, Harris AM, Goede D, Jakub JW, Hieken TJ, Degnim AC. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012 Oct; 19 (10):3205-11 Epub 2012 July 06
    View PubMed
  150. Tragos C, Hieken TJ. Optimizing the management of cutaneous melanoma in the elderly. Surgery. 2011 Oct; 150(4):828-35.
    View PubMed
  151. Ough M, Velasco J, Hieken TJ. A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression. Am J Surg. 2011 May; 201(5):692-4. Epub 2010 Sep 18.
    View PubMed
  152. Kukreja SS, Esteban-Agusti E, Velasco JM, Hieken TJ. Increased lymph node evaluation with colorectal cancer resection: does it improve detection of stage III disease? Arch Surg. 2009 Jul; 144(7):612-7.
    View PubMed
  153. Erickson Foster J, Velasco JM, Hieken TJ. Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol. 2008 Sep; 15(9):2395-402. Epub 2008 Jul 04.
    View PubMed
  154. Erickson JL, Velasco JM, Hieken TJ. Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables. Ann Surg Oncol. 2008 Apr; 15(4):1211-7. Epub 2008 Feb 01.
    View PubMed
  155. Hieken TJ, Cheregi J, Farolan M, Kim J, Velasco JM. Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up. Am J Surg. 2007 Oct; 194(4):504-6.
    View PubMed
  156. Hieken TJ, Velasco JM. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer? Surgery. 2006 Oct; 140(4):500-7; discussion 507-8.
    View PubMed
  157. Hieken TJ, Nettnin S, Velasco JM. The value of sentinel lymph node biopsy in elderly breast cancer patients. Am J Surg. 2004 Oct; 188(4):440-2.
    View PubMed
  158. Hieken TJ. Sentinel node biopsy for skin cancer. eMedicine Journal Dermatology. 2001 Nov 20; 2(11).
  159. Hieken TJ, Harrison J, Herreros J, Velasco JM. Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg. 2001 Oct; 182(4):351-4.
    View PubMed
  160. Hieken TJ, Farolan M, D'Alessandro S, Velasco JM. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers. Surgery. 2001 Oct; 130(4):593-600; discussion 600-1.
    View PubMed
  161. Velasco JM, Rossi H, Hieken TJ, Fernandez M. Laparoscopic ultrasound enhances diagnostic laparoscopy in the staging of intra-abdominal neoplasms. Am Surg. 2000 Apr; 66(4):407-11.
    View PubMed
  162. Hieken TJ, Ronan SG, Farolan M, Shilkaitis AL, Das Gupta TK. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer. 1999 Jan 15; 85(2):375-82.
    View PubMed
  163. Velasco JM, Vallina VL, Bonomo SR, Hieken TJ. Postlaparoscopic small bowel obstruction. Rethinking its management. Surg Endosc. 1998 Aug; 12(8):1043-5.
    View PubMed
  164. Mehta RR, McDermott JH, Hieken TJ, Marler KC, Patel MK, Wild LD, Das Gupta TK. Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy. J Clin Oncol. 1998 Jul; 16(7):2409-16.
    View PubMed
  165. Hieken TJ, Velasco JM. A prospective analysis of office-based breast ultrasound. Arch Surg. 1998 May; 133(5):504-7; discussion 507-8.
    View PubMed
  166. Hieken TJ, Das Gupta TK. Mutant p53 expression: a marker of diminished survival in well-differentiated soft tissue sarcoma. Clin Cancer Res. 1996 Aug; 2(8):1391-5.
    View PubMed
  167. Hieken TJ, Ronan SG, Farolan M, Shilkaitis AL, Das Gupta TK. Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma. Anticancer Res. 1996 Jul-Aug; 16(4B):2321-4.
    View PubMed
  168. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L, Das Gupta TK. Beta3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res. 1996 Jun; 63(1):169-73.
    View PubMed
  169. Hieken TJ, Das Gupta TK. Co-expression of mutant p53 and mdm2 proteins in human liposarcoma. Surg Forum. 1996; 47:499-501.
  170. Hieken TJ, Ronan SG, Farolan M, Shilkaitis AL, Kim DK, Das Gupta TK. Beta 1 integrin expression in malignant melanoma predicts occult lymph node metastases. Surgery. 1995 Oct; 118(4):669-73; discussion 673-5.
    View PubMed
  171. Pisha E, Chai H, Lee IS, Wickramaratre M, Chaquedera T, Thawatchai R, Soljarto D, Farnsworth NR, Cordell G, Beecher CWW, Fong HSS, Kinghorn AD, Borwn DM, Wani M, Wall ME, Hieken TJ, Das Gupta TK, Pezzuto JM. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis Nature Medicine. 1995; 1(10):1046-51.
  172. Ridgeway CA, Hieken TJ, Ronan SG, Kim DK, Das Gupta TK. Acral lentiginous malignant melanoma. Arch Surg. 1995; 130:88-92.
  173. Hieken TJ, Rauth S, Ronan SG, Das Gupta TK. Hereditary melanoma. Surg Oncol Clin North Amer. 1994; 3(3):563-77.
  174. Hieken TJ, Birkett DH. Postoperative T-tube tract choledochoscopy. Am J Surg. 1992 Jan; 163(1):28-30; discussion 30-1.
    View PubMed
  175. Hieken TJ, Sheppard JE. An abductor digit minimi myocutaneous flap for thenar eminence reconstruction. Contemporary Orthopaedics. 1988; 17(1):33-42.